Aveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition

Shares of Cambridge, Mass.-based AVEO Oncology have taken a wild ride over the past day. The stock skyrocketed more than 45 percent Wednesday on rumors of a possible acquisition. However, overnight and in premarket trading, the stock has lost about 5 percent of its gains.